66. IgA nephropathy Clinical trials / Disease details
Clinical trials : 275 / Drugs : 258 - (DrugBank : 82) / Drug target genes : 36 - Drug target pathways : 140
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ITMCTR2000004074 | 2020-11-15 | 2020-11-23 | Study on dose-effect relationship and safety of Modified Huangqi Chifeng Decoction with different doses of Astragalus in the treatment of IgA nephroproteinuria | Study on dose-effect relationship and safety of Modified Huangqi Chifeng Decoction with different doses of Astragalus in the treatment of IgA nephroproteinuria | IgA nephropathy | Experimental group 3:Modified Huangqi Chifeng Decoction 3 + telmisartan tablet;control group:Placebo + telmisartan tablet;Experimental group 1:Modified Huangqi Chifeng Decoction 1 + telmisartan tablet;Experimental group 2:Modified Huangqi Chifeng Decoction 2 + telmisartan tablet; | Xiyuan Hospital, China Academy of Chinese Medical Sciences | NULL | Pending | Both | Experimental group 3:30;control group:30;Experimental group 1:30;Experimental group 2:30; | N/A | China | ||
| 2 | ChiCTR2000040161 | 2020-11-15 | 2020-11-23 | Study on dose-effect relationship and safety of Modified Huangqi Chifeng Decoction with different doses of Astragalus in the treatment of IgA nephroproteinuria | Study on dose-effect relationship and safety of Modified Huangqi Chifeng Decoction with different doses of Astragalus in the treatment of IgA nephroproteinuria | IgA nephropathy | control group:Placebo + telmisartan tablet;Experimental group 1:Modified Huangqi Chifeng Decoction 1 + telmisartan tablet;Experimental group 2:Modified Huangqi Chifeng Decoction 2 + telmisartan tablet;Experimental group 3:Modified Huangqi Chifeng Decoction 3 + telmisartan tablet; | Xiyuan Hospital, China Academy of Chinese Medical Sciences | NULL | Pending | Both | control group:30;Experimental group 1:30;Experimental group 2:30;Experimental group 3:30; | N/A | China | ||
| 3 | ChiCTR-TRC-10000776 | 2010-02-27 | 2010-02-10 | A Study on the Efficacy and Safety of Telmisartan, Clopidogrelin and Leflunomide in patients with IgA nephropathy | A Study on the Efficacy and Safety of Telmisartan, Clopidogrelin and Leflunomide in patients with IgA nephropathy | lgA nephropathy;ICD:N03.8 | 1:Telmisartan+ Clopidogrelin placebo + Leflunomide placebo ;2:Telmisartan + Clopidogrelin+ Leflunomide placebo ;3:Telmisartan + Clopidogrelin placebo + Leflunomide;4:Telmisartan + Clopidogrelin + Leflunomide; | Chinese General Hospital of PLA | NULL | Completed | 18 | 55 | Both | 1:100;2:100;3:100;4:100; | China |